Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Equity Income (2016 - 2026)

Pediatrix Medical (MD) has disclosed Equity Income for 12 consecutive years, with $843000.0 as the latest value for Q4 2025.

  • Quarterly Equity Income fell 8.07% to $843000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, up 54.99% year-over-year, with the annual reading at $3.6 million for FY2025, 54.99% up from the prior year.
  • Equity Income for Q4 2025 was $843000.0 at Pediatrix Medical, down from $1.9 million in the prior quarter.
  • The five-year high for Equity Income was $1.9 million in Q3 2025, with the low at $290000.0 in Q4 2021.
  • Average Equity Income over 5 years is $583400.0, with a median of $492500.0 recorded in 2021.
  • The sharpest move saw Equity Income tumbled 42.46% in 2021, then soared 322.25% in 2025.
  • Over 5 years, Equity Income stood at $290000.0 in 2021, then surged by 38.97% to $403000.0 in 2022, then rose by 18.86% to $479000.0 in 2023, then surged by 91.44% to $917000.0 in 2024, then decreased by 8.07% to $843000.0 in 2025.
  • According to Business Quant data, Equity Income over the past three periods came in at $843000.0, $1.9 million, and $505000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.